Roundup Lawsuit October 2026: $7.25B Settlement Still Awaits the Judge — and a New Trial Just Opened in St. Louis
As of October 2026, the proposed $7.25 billion Roundup class settlement still awaits a ruling from a St. Louis judge after its September 14 hearing, while 1,104 cases remain in the federal MDL. A new three-plaintiff trial opened September 29 in St. Louis County — the first testing a design-defect theory since the Supreme Court barred failure-to-warn claims in June.
Key facts
- A proposed $7.25 billion class settlement was announced in February 2026; the final-approval hearing took place on September 14, 2026, and the judge had not ruled as of early October.
- In Monsanto Co. v. Durnell (June 25, 2026), the U.S. Supreme Court ruled 7–2 that federal law preempts state failure-to-warn claims requiring a cancer warning on Roundup's label.
- On October 1, 2026, 1,104 cases were pending in the federal Roundup MDL — down from 3,925 a month earlier as settled cases were dismissed.
- Aretino v. Monsanto, a three-plaintiff trial in St. Louis County, opened on September 29, 2026, and is expected to run four to five weeks on a design-defect theory.
- Bayer had previously agreed to a $10.9 billion Roundup settlement in 2020 resolving most existing claims at that time.
Where the $7.25 billion settlement stands
A class settlement resolves claims for a defined group of people — the "class" — in a single deal rather than case by case. The proposed Roundup class settlement, announced on February 17, 2026, is designed to resolve both current and future personal-injury claims alleging that Roundup exposure caused non-Hodgkin lymphoma. A judge granted preliminary approval in early March 2026, and the fairness hearing — the proceeding where the court decides whether the deal treats class members fairly — took place on September 14, 2026, before Judge Timothy Boyer of the St. Louis City Circuit Court, after two postponements.
As of early October 2026, Judge Boyer had not issued a ruling, and claims cannot be filed under the settlement until he approves it. Objectors challenged the settlement's notice and opt-out process as well as a $675 million attorney-fee request. On August 27, 2026, the Eighth Circuit Court of Appeals rejected objectors' attempt to move the approval decision to federal court, leaving the final call with Judge Boyer. The opt-out deadline for class members — June 4, 2026 — has already passed.
The Supreme Court ruling that reshaped every case
On June 25, 2026, the U.S. Supreme Court decided Monsanto Co. v. Durnell by a 7–2 vote. The case concerned the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) — the federal law that controls what appears on pesticide labels. The Court held that federal law preempts, meaning overrides, state failure-to-warn claims that would require a cancer warning on Roundup's EPA-approved label. A failure-to-warn claim is the legal theory that a manufacturer is liable for not warning users about a known risk.
The effect is sweeping: the warning-label theory powered most Roundup cases for years, and those claims now face dismissal. But design-defect claims — the theory that the product itself was unreasonably dangerous — were not resolved by Durnell, and other theories remain live. Every pending and future claim is now a case-by-case question of which theory it rests on.
Aretino v. Monsanto: the new trial testing design defect
Opening statements began on September 29, 2026, in St. Louis County in Aretino v. Monsanto, a trial featuring three plaintiffs: Theresa Aretino, Cynthia Fernandez (whose claim is being pursued after her death), and Betty Larkin. All three developed non-Hodgkin lymphoma and allege Roundup exposure caused it. Because Durnell bars the warning-label argument, the plaintiffs are pursuing design-defect and inadequate-testing claims instead. Their attorney, Greg Dovel, argued that Monsanto did not adequately test Roundup before bringing it to market. Bayer's attorney, Paul Boehm, countered that the plaintiffs cannot prove glyphosate is too dangerous to be sold at all, pointing to decades of regulatory safety reviews. The trial is expected to run four to five weeks — the first test of design-defect theories in the post-Durnell era.
The federal MDL by the numbers
An MDL — multidistrict litigation — is a procedure that consolidates federal cases before a single judge for pretrial proceedings. In the Roundup MDL (MDL 2741), the Judicial Panel on Multidistrict Litigation reported 1,104 cases pending on October 1, 2026, down sharply from 3,925 a month earlier. That drop reflects stipulated dismissals of settled cases entered in batches through September — not mass dismissals under Durnell. Nationwide, combining federal and state courts, an estimated 60,000 to 65,000 Roundup cases were pending as of March 2026. New lawsuits continue to be filed. For a parallel view of another pesticide MDL, see our October 2026 update on the Paraquat lawsuit, and for the firefighting-foam litigation, our October 2026 AFFF update.
Who can still file or join a Roundup claim
The claims at issue generally involve people diagnosed with non-Hodgkin lymphoma — and certain related blood cancers such as chronic lymphocytic leukemia — after substantial exposure to Roundup or other glyphosate-based herbicides, often through farm, landscaping, or groundskeeping work. If the $7.25 billion class settlement wins approval, class members who did not opt out would be covered by its claims process. Those who opted out by the June 4, 2026 deadline, or whose circumstances fall outside the class definition, must pursue individual claims — our guide to hiring a Roundup lawyer explains how that process works. Either way, state statutes of limitations — the legal filing deadlines — are unforgiving, and waiting for the ruling before seeking a case review is a mistake.
What compensation looks like — documented figures only
Compensation varies widely by case, and most individual settlement amounts are confidential. The figures that can be stated with confidence are the documented program numbers: the proposed settlement's official FAQ lists average awards of $10,000 to $165,000 by injury tier, plus quick-pay awards of $6,000 to $14,500 — program figures that describe the settlement's structure, not a promise for any individual. Among named verdicts, a Georgia jury awarded $2.1 billion in the Barnes case in March 2025. By February 2026, Bayer listed only three adverse verdicts still outstanding: Anderson, Dennis, and Durnell. Mass-tort firms typically work on contingency, meaning no upfront fee and payment only from a recovery. For a plain-language walkthrough of how cases like these work, see the Problem Solved channel.
This article is general information about ongoing litigation, not legal advice. For advice about your situation, consult a licensed attorney.
Who Benefits From This — and Who Does Not
The Roundup litigation in October 2026 matters most to claimants whose legal theory survived the Supreme Court — and to everyone waiting on the $7.25 billion settlement.
Who benefits:
- Claimants with design-defect theories: the Durnell ruling bars only failure-to-warn claims based on the label, while design-defect and other theories survive and are being tested in the Aretino trial, which opened September 29 in St. Louis County.
- People already in the federal MDL: 1,104 cases remain in the federal MDL, so the litigation continues even while the class settlement awaits a ruling.
- People awaiting the proposed $7.25 billion settlement: its official FAQ lists tiered averages of $10,000 to $165,000 and quick-pay awards of $6,000 to $14,500 — program figures that will matter only if the judge approves the deal.
Who benefits little or not at all:
- People wanting to file under the settlement now: as of October 2026, the St. Louis judge had not ruled following the September 14 fairness hearing, and claims cannot be filed under the settlement until it is approved.
- Failure-to-warn-only claimants: Durnell bars those claims, so each case is now evaluated on its own legal theory.
- Class members who missed opt-out: the class settlement’s opt-out deadline of June 4, 2026, has passed; for individual claims, state statutes of limitations apply.
Related reading: Camp Lejeune Lawsuit Update October 2026: $1.1B in Offers, First Trials Begin October 26 — Where Your Claim Stands.
Frequently asked questions
Is the $7.25 billion Roundup settlement approved yet?
No. As of October 2026, the St. Louis judge had not ruled following the September 14 fairness hearing, and claims cannot be filed under the settlement until it is approved.
Can I still file a Roundup lawsuit after the Supreme Court's Durnell ruling?
Possibly. Durnell bars only failure-to-warn claims based on the label; design-defect and other theories survive and are being tested in the Aretino trial. Each case is now evaluated on its own legal theory.
How much is a Roundup claim worth?
It varies widely by case, and most individual settlements are confidential. The proposed settlement's official FAQ lists tiered averages of $10,000 to $165,000 and quick-pay awards of $6,000 to $14,500 — program figures, not guarantees for any individual.
What is the deadline to join a Roundup claim?
The class settlement's opt-out deadline of June 4, 2026, has passed. For individual claims, state statutes of limitations apply, so get a case review promptly rather than waiting.
Who benefits from the Roundup litigation in October 2026 — and who does not?
Claimants with design-defect theories benefit most, since Durnell bars only failure-to-warn label claims and the Aretino trial is now testing design defect, along with the 1,104 cases remaining in the federal MDL and everyone awaiting the proposed $7.25 billion settlement. It fits poorly if you want to file under the settlement now, since the judge had not ruled after the September 14 fairness hearing, if your claim rests only on failure to warn, or if you missed the June 4, 2026 class opt-out deadline.
How do I start or join a Roundup claim?
First identify your legal theory, since failure-to-warn label claims are barred by Durnell while design-defect and other theories survive. Then get a case review promptly rather than waiting: the class settlement cannot accept claims until the judge approves it, and individual claims are governed by state statutes of limitations.